Method for examining kidney diseases

a kidney disease and kidney prognosis technology, applied in the field can solve the problems of not being able to establish a decisive method for accurate diagnosis of kidney disease prognosis, and aiming at the existence of such a method in the tissues, and achieve the effect of improving the prognosis

Inactive Publication Date: 2007-10-18
CMIC
View PDF1 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0017] Among them, L-FABP distributes at the proximal tubule, but according to the findings of the present inventors, the existence of the L-FABP is

Problems solved by technology

However, no decisive method has actually been established yet for accurate diagnosis of the prognosis of kidney diseases, and it has been desired to develop a useful method for diagnosis and for examination.
However, they do no

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for examining kidney diseases
  • Method for examining kidney diseases
  • Method for examining kidney diseases

Examples

Experimental program
Comparison scheme
Effect test

example 1

Preparation (I) of Antibody Binding to FABP in Human Kidney Tissue (Preparation of Anti-mouse FABP Antibody):

(1) Anti-mouse L-FABP Polyclonal Antibody:

[0060] FABP existing at the human proximal tubule has been known to be mainly a liver-type FABP (L-FABP). Human L-FABP and mouse L-FABP have a high homology, and as an antibody binding to L-FABP in human kidney tissues, anti-mouse L-FABP antibody may be used.

[0061] Thus, an anti-mouse L-FABP polyclonal antibody was prepared. The antigen, mouse L-FABP, was prepared according to the method disclosed in the literature (Takahashi et al., Eur. J. Biochem., vol. 136, p. 589-601, 1983), as follows. That is, to the excised liver from a mouse killed by bleeding was added a four-time volume of 30 mM Tris-HCl buffer (pH 8), and the mixture was treated by a polythoron-type homogenizer. The resultant was centrifuged at 8000 rpm for 15 minutes, and the supernatant thus obtained was further ultra-centrifuged at 100,000×g for 90 minutes to give ...

example 2

Preparation (II) of Antibody Binding to FABP in Human Kidney Tissues (Preparation of Anti-human L-FABP Antibody):

(1) Purification of Recombinant Human L-FABP:

[0065] cDNA of human L-FABP was obtained by PCR (polymerase chain reaction) from the .cDNA library derived from human liver (manufactured by CLONTECH Laboratories Inc., Cat # HL1115b Lot # 5621). An oligonucleotide of 23 to 27 mers synthesized by a DNA synthesizer was used as a primer. The necleotide sequence of the primer was designed based on the gene sequence of human L-FABP disclosed in the literature (Lowe et al., J. Biol. Chem., vol. 260, p. 3413-3417, 1985) and Gene Data Base (GENBANK Accession No. M10617), with adding a restriction enzyme recognition site for inserting an expression vector at the end of the primer. The obtained DNA fragment (about 420 base pairs) has a BamHI recognition site before the initiation codon, and the BamHI recognition site after the termination codon, and encodes the desired full-length h...

example 3

Localization of FABP in Human Kidney Tissues (Normal Kidney Tissues):

[0071] Normal human kidney tissues were subjected to immunohisto staining of FABP. The human kidney tissues were normal portions of the kidney excised from the patient with renal cancer. A primary antibody for L-FABP staining was the anti-mouse L-FABP polyclonal antibody (IgG) prepared in the same manner as in Example 1-(1). A primary antibody for H-FABP staining was the anti-mouse H-FABP polyclonal antibody (IgG) prepared in the same manner as in Example 1-(2). The immunostaining was carried out using Vectastain ABC kit (manufactured by Vector Laboratory, Inc.), and a secondary antibody was a biotinylated anti-rabbit IgG, and an enzyme was a biotinylated horseradish peroxidase, and a coloring substrate was DAB (3,3′-diaminobensidine tetrahydrochloride).

[0072] The results are shown in FIG. 1. When anti-L-FABP antibody was used, the proximal tubule was stained. On the other hand, when anti-H-FABP antibody was use...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Method for examining kidney disease, which comprises detecting fatty acid binding protein derived from kidney tissues, which is present in specimen collected from mammal excluding Rodents. By the present method, it is possible to obtain test results which may be very important information for diagnosis of prognosis of kidney disease, that has been very difficult in the past. Based on test results obtained by the present method, it may be possible to select a suitable method for treatment of kidney disease with taking into consideration risks as to the prognosis, etc. Besides, the present method can be applied to, in addition to the kidney tissue samples, urine samples as well, so that the examination procedure can be simple and efficient.

Description

[0001] This application is a Continuation of application Ser. No. 09 / 578,693 filed on May 26, 2000, which is a continuation-in-part application of PCT International Application No. PCT / JP98 / 05319 which has an international filing date of Nov. 26, 1998 which designated the United States, the entire contents of which are incorporated by reference. This application also claims priority to JP1997-323684, filed Nov. 26, 1997 in Japan, the entire contents of which are incorporated by reference.TECHNICAL FIELD [0002] The present invention relates to a method for examination for diagnosing the prognosis, etc. of kidney diseases. BACKGROUND ART [0003] Kidney diseases such as chronic nephritis usually show complicated and various symptoms, and for such kidney diseases, it is important to apply a suitable treatment thereto as early as possible so that a transition into chronic renal insufficiency, which requires dialysis treatment, can be avoided, or can be delayed as long as possible. In case...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G01N33/53G01N33/68
CPCG01N2800/347G01N33/6893
Inventor YAMANOUCHI, MASAYAHONDA, AKIKOHASE, HIROMISUGAYA, TAKESHIKIMURA, KENJIRO
Owner CMIC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap